These increased levels often occur during exacerbations of the diseases and correlate with biomarkers of disease activity, suggesting that the expression of IL37 corresponds to the disease activity of RA, ankylosing spondylitis (AS), Graves’ disease (GD), and SLE [25,26,27,28]. This evidence concerns the gene IL37 and systemic lupus erythematosus.